Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,728.80
+23.35(+0.41%)
Dow 30
42,052.19
+288.73(+0.69%)
Nasdaq
18,239.92
+144.77(+0.80%)
Russell 2000
2,210.13
+13.48(+0.61%)
Crude Oil
69.33
+0.07(+0.10%)
Gold
2,745.90
-3.40(-0.12%)

BlackRock Health Sciences Term Trust (BMEZ)

NYSE - Nasdaq Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

15.79

+0.36

(+2.33%)

At close: 04:00PM EDT

15.70

-0.09

(-0.57%)

After hours:

05:38PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	1.64B
Enterprise Value	N/A
Trailing P/E	21.49
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	23.37
Price/Book (mrq)	0.88
Enterprise Value/Revenue	23.38
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	N/A
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	16.59
52 Week Low ³	13.29
50-Day Moving Average ³	15.82
200-Day Moving Average ³	15.62

Share Statistics

Avg Vol (3 month) ³	189.8k
Avg Vol (10 day) ³	200.3k
Shares Outstanding ⁵	103.85M
Implied Shares Outstanding ⁶	N/A
Float ⁸	N/A
% Held by Insiders ¹	0.02%
% Held by Institutions ¹	26.49%
Shares Short (Sep 29, 2023) ⁴	479.22k
Short Ratio (Sep 29, 2023) ⁴	0.89
Short % of Float (Sep 29, 2023) ⁴	0.44%
Short % of Shares Outstanding (Sep 29, 2023) ⁴	0.44%
Shares Short (prior month Aug 31, 2023) ⁴	7.25k

Dividends & Splits

Forward Annual Dividend Rate ⁴	1.12
Forward Annual Dividend Yield ⁴	8.10%
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	316.36%
Dividend Date ³	Mar 31, 2023
Ex-Dividend Date ⁴	Oct 13, 2023
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	N/A
Most Recent Quarter (mrq)	N/A

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	N/A
Return on Equity (ttm)	N/A

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	N/A
Diluted EPS (ttm)	-0.16
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	N/A
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	N/A
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	N/A
Book Value Per Share (mrq)	N/A

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A